Intensive treatment of acute leukemia in adults 70 years of age and older
Open Access
- 15 July 1987
- Vol. 60 (2) , 149-155
- https://doi.org/10.1002/1097-0142(19870715)60:2<149::aid-cncr2820600204>3.0.co;2-f
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implications.Journal of Clinical Investigation, 1985
- Difference between young and old patients in characteristics of leukemic cells: Older patients have cells growing excessively in vitro, with low antigenicity despite high HLA‐DR antigensAmerican Journal of Hematology, 1984
- A collaborative study of the relationship of the morphological type of acute nonlymphocytic leukemia with patient age and karyotypeBlood, 1982
- Acute Nonlymphocytic Leukemia in the Elderly: Biology and TreatmentPublished by Springer Nature ,1982
- Treatment of acute myelocytic leukemia: a study by cancer and leukemia group BBlood, 1981
- Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemiaBlood, 1981
- Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP)Blood, 1981
- A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemiaCancer, 1981
- The Therapy of Acute Granulocytic Leukemia in Patients More Than Fifty Years OldAnnals of Internal Medicine, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958